“Effective airway clearance on a daily basis at home is the key to keeping chronic lung patients stable and breaking the vicious cycle of clinical deteriorations,” said Dr. Moshe Ashkenazi, pediatric pulmonologist and deputy director at Safra Children’s Hospital, Sheba Medical Center, and Synchrony Medical's co-founder.
Synchrony Medical has developed a novel airway clearance system based on a unique chest physiotherapy method developed at the National Cystic Fibrosis Center of Israel, Sheba Medical Center. The system includes real time sensing for an adaptive treatment to achieve effective airway clearance. Synchrony’s system will enable patients to receive high quality chest physiotherapy independently at the comfort of their home. The system synchronizes a unique chest compression sequence and the delivery of positive airway pressure with the patient's breathing cycle, according to a personalized treatment algorithm. It is based on a unique airway clearance method developed at the National CF Center of Israel, at the Sheba Medical Center.
"Our system will enable patients to receive state-of-the-art chest physiotherapy independently, in the comfort of their own home,” explained Anat Shani, CEO of Synchrony Medical. “By making this effective therapy accessible, Synchrony Medical will bring to patient’s years of experience from Sheba’s respiratory experts and may help minimize pulmonary exacerbations and costly hospitalization associated with chronic lung diseases. This trial brings us one step closer to our goal: improving the lives of millions of chronic lung disease patients who deserve better airway clearance solutions.”
Synchrony Medical is a portfolio company of MEDX Xelerator, a medical device incubator formed as an initiative of MEDX Ventures Group together with Boston Scientific, Intellectual Ventures and Sheba Medical Center.